Sony Biotechnology Inc.

Sony Biotechnology Inc., doing business as Sony Corp of America, manufactures and sells advanced flow cytometry and cell sorting instrumentation, along with associated preventive maintenance and repair services, to federal research agencies exclusively as a prime contractor — 143 awards spanning NIH institutes, CDC, VA, USDA, DOD, and FDA across the past two decades. Sony Biotechnology does not compete under small business set-asides; all awards are full-and-open, unrestricted procurements that reflect the specialized and often sole-source nature of its products and the company's exclusive control over proprietary diagnostic systems, firmware, and OEM-certified replacement parts for its equipment.

Sony Biotechnology's customer concentration is heavily weighted toward National Institutes of Health institutes and other HHS components. The National Cancer Institute alone accounts for 37 awards (26% of the 143-award footprint) worth $4.7 million in combined potential value; the National Institute of Allergy and Infectious Diseases follows with 12 awards valued at $2.1 million; and the National Institute on Drug Abuse, Food and Drug Administration, and National Institute on Aging round out the top-five customer set, collectively representing 52% of awards and 51% of combined potential value. Work spreads across HHS component institutes — National Center for Advancing Translational Sciences, National Institute of Child Health and Human Development, National Institute of Neurological Disorders and Stroke, and NIH Clinical Center — plus the CDC, Veterans Integrated Service Networks, USDA Agricultural Research Service, Air Force Research Laboratory, and Army Corps of Engineers. The concentration signal is clear: Sony's federal market is biomedical research infrastructure, anchored in HHS.

Sony's capability portfolio centers on two concurrent revenue streams: equipment sales (spectral flow cytometers and cell sorters such as the ID7000, MA900, SH800, and SH800SFP models) and multi-year preventive maintenance and on-site support contracts. Recent representative contracts illustrate both: a $447,107 purchase order from the National Institute of Allergy and Infectious Diseases in September 2024 for delivery of a Sony ID7000 Spectral Flow Cytometer with five lasers, including workstation, training, and shipping; a $470 thousand award from USDA Agricultural Research Service in September 2024 for a full-spectrum flow cytometer with five excitation lasers and 147 detectors; and recurring maintenance contracts such as a $152,280 purchase order from the National Cancer Institute in July 2026 for one-year system maintenance on a Sony MA900 cell sorter (base plus four one-year option periods extending through July 2031). The maintenance work includes preventive maintenance visits, unlimited telephone and on-site support, software and firmware updates, and OEM-certified parts replacement — services Sony provides directly because it controls all proprietary diagnostic systems and authorized field service engineers. Several contracts note sole-source justification, reflecting Sony's exclusive position as the manufacturer and sole authorized provider for its instrumentation.

Activity has been recent and steady. Awards per year over the past five years show 7 in 2022, 14 in 2023, 18 in 2024, and 3 in 2025 (through mid-year), with 6 awards already recorded in 2026. Combined potential value across all 143 awards in the source data stands at $20.4 million, with $18.7 million obligated (91% of potential value), reflecting the firm fixed-price, purchase-order structure of Sony's federal work. Thirteen awards carrying combined potential value of $1.9 million face ultimate completion dates in the next twenty-four months and represent recompete exposure for Sony and opportunity for competitors.

Sony Biotechnology does not subcontract on federal prime work — the 143-award footprint is 100% prime awards with zero sub-award footprint. The vendor operates as a parent corporation headquartered in San Jose, California, with named subsidiaries including Sony Manufacturing Systems America Inc., Sony Electronics Inc., Sony Pictures Entertainment Inc., and others, reflecting the broader Sony corporate structure. Category concentration reveals 72 awards under NAICS 811210 (Analytical Laboratory Instrument Manufacturing) and 42 awards under PSC J066 (Other Electronic and Precision Equipment Repair and Maintenance) — both reflecting Sony's role as both original equipment manufacturer and dedicated OEM maintenance provider. No parent vehicles (GWACs, agency-wide IDIQs, or BPAs) appear in the top parent vehicles block; Sony operates through direct purchase orders and firm fixed-price contracts, not through multi-agency vehicles.